Onyx Provides Drug Trial Data to Amgen, Other Potential Bidders

23.08.2013 - Onyx Pharmaceuticals has given potential buyers, including Amgen, access to trial data on its new cancer drug, removing a key hurdle that was holding up deal talks, according to...